Dynavax to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 11
February 24 2020 - 4:05PM
Dynavax Technologies Corporation (NASDAQ: DVAX), a
biopharmaceutical company focused on developing and commercializing
novel vaccines, will report fourth quarter and full year 2019
financial results on Wednesday, March 11, 2020, after the U.S.
financial markets close.
Dynavax will host a conference call and live
audio webcast on Wednesday, March 11, 2019 at 4:30 p.m. (ET)/1:30
p.m. (PT).
The live audio webcast may be accessed through
the “Events & Presentations” page on the “Investors” section of
the Company’s website at www.dynavax.com. Alternatively,
participants may dial 800-458-4121 (domestic) or 720-543-0206
(international) and refer to conference ID 1989638. A replay of the
webcast will be available for 30 days following the live event.
About DynavaxDynavax is a
commercial stage biopharmaceutical company developing and
commercializing novel vaccines. The Company launched its first
commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant),
Adjuvanted], in February 2018, following U.S. FDA approval for
prevention of infection caused by all known subtypes of hepatitis B
virus in adults age 18 years and older. For more information, visit
www.dynavax.com and follow the company on LinkedIn.
Contacts:Nicole Arndt, Senior
Manager, Investor Relationsnarndt@dynavax.com510-665-7264
Derek Cole, President Investor Relations
Advisory Solutionsderek.cole@IRadvisory.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024